0000950170-24-066889.txt : 20240530 0000950170-24-066889.hdr.sgml : 20240530 20240530210053 ACCESSION NUMBER: 0000950170-24-066889 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240528 FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robb Gary Charles CENTRAL INDEX KEY: 0001529655 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 241007296 MAIL ADDRESS: STREET 1: C/O 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 ownership.xml 4 X0508 4 2024-05-28 0001088856 CORCEPT THERAPEUTICS INC CORT 0001529655 Robb Gary Charles C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 false true false false Chief Business Officer true Common Stock 2024-05-28 4 M false 11000 3.29 A 31203 D Common Stock 2024-05-28 4 S false 11000 30.3904 D 20203 D Common Stock 7700 I Custodial Account for Child Common Stock 8700 I Custodial Account for Child Common Stock 8700 I Custodial Account for Child Stock option (right to buy) 3.29 2024-05-28 4 M false 11000 0.00 D 2025-02-18 Common Stock 11000 50037 D Includes 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023, 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, and 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction. Represents the weighted average sale price for entire number of shares sold. The actual sale prices range from $29.25 to $32.00. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. Fully exercisable. The power of attorney under which this form was signed is on file with the Commission. /s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb. 2024-05-30